US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Whitehawk Therapeutics, Inc.

4.11

+0.04000.98%

Post-market: 4.110.00000.00%19:30 EDT

Volume:283.52K

Turnover:1.18M

Market Cap:234.31M

PE:-3.69

High:4.30

Open:4.12

Low:4.08

Close:4.07

52wk High:5.50

52wk Low:1.80

Shares:57.01M

Float Shares:28.74M

Volume Ratio:0.70

T/O Rate:0.99%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.1137

EPS(LYR):-0.3328

ROE:-44.98%

ROA:-28.70%

PB:1.28

PE(LYR):-12.35

Loading ...

Overview Company News Filings

Whitehawk Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Whitehawk Therapeutics posts corporate deck outlining three-asset antibody-drug conjugate pipeline

Whitehawk Q1 net loss turns to USD 22.2 million

WhiteHawk Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights

THOMSON REUTERS

Whitehawk Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview

Whitehawk Therapeutics announces annual shareholder meeting

Whitehawk Therapeutics' Antibody Drug Conjugates Indicate Potential Efficacy Against Cancer, Oppenheimer Says

MT Newswires Live

Oppenheimer Sticks to Their Buy Rating for Whitehawk Therapeutics (WHWK)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Whitehawk Therapeutics (WHWK), COMPASS Pathways (CMPS) and Monopar Therapeutics Inc (MNPR)

Whitehawk Therapeutics publishes HWK-016 preclinical presentation on MUC16-targeting ADC

Whitehawk announces presentation of new preclinical data across ADC portfolio

Whitehawk says Phase 1 trial for HWK-016 ADC in ovarian, endometrial cancers ongoing

Whitehawk Therapeutics CEO joins Jones Trading Post-AACR virtual fireside chat

Whitehawk Therapeutics publishes ovarian cancer MUC16 expression study presentation

Trade Alert: President Of Whitehawk Therapeutics David Lennon Has Sold Stock

Simply Wall St.

Whitehawk Therapeutics presents analysis of MUC16 at SGO

Whitehawk says Phase 1 trial tests MUC16-targeted ADC HWK-016 in gynecologic cancers

JonesTrading Sticks to Their Buy Rating for Whitehawk Therapeutics (WHWK)

Whitehawk Therapeutics to present three preclinical ADC abstracts at AACR Annual Meeting 2026

Whitehawk Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/WHWK/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"WHWK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WHWK\",,,,,undefined,":{"symbol":"WHWK","market":"US","secType":"STK","nameCN":"Whitehawk Therapeutics, Inc.","latestPrice":4.11,"timestamp":1789156800000,"preClose":4.07,"halted":0,"volume":283519,"hourTrading":{"tag":"盘后","latestPrice":4.11,"preClose":4.11,"latestTime":"19:30 EDT","volume":3154,"amount":12962.94,"timestamp":1789169406385,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.009828009828009836,"floatShares":28743300,"shares":57009000,"eps":-1.1137,"marketStatus":"Market Closed","change":0.04,"latestTime":"09-11 16:00:00 EDT","open":4.12,"high":4.3,"low":4.08,"amount":1180101.340384,"amplitude":0.054054,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.1137,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":4.07,"postHourTrading":{"tag":"盘后","latestPrice":4.11,"preClose":4.11,"latestTime":"19:30 EDT","volume":3154,"amount":12962.94,"timestamp":1789169406385,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7010155264134541,"impliedVol":0.6847,"impliedVolPercentile":0.1833},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WHWK\",,,,,undefined,":{"symbol":"WHWK","floatShares":28743300,"roa":"-28.70%","roe":"-44.98%","lyrEps":-0.332801,"volumeRatio":0.7010155264134541,"shares":57009000,"dividePrice":0,"high":4.3,"amplitude":0.054054,"preClose":4.07,"low":4.08,"week52Low":1.8,"pbRate":"1.28","week52High":5.495,"institutionHeld":0,"latestPrice":4.11,"eps":-1.1137,"divideRate":0,"volume":283519,"delay":0,"ttmEps":-1.1137,"open":4.12,"prevYearClose":2.42,"prevWeekClose":4.6,"prevMonthClose":4.54,"prevQuarterClose":4.58,"fiveDayClose":4.63,"twentyDayClose":4.68,"sixtyDayClose":4.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WHWK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"WHWK","fiscalQuarterEnding":"2026/06","expectedEps":-0.3,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2026-05-07","symbol":"WHWK","fiscalQuarterEnding":"2026/03","expectedEps":-0.36,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2026-03-12","symbol":"WHWK","fiscalQuarterEnding":"2025/12","expectedEps":-0.55,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2025-11-06","symbol":"WHWK","fiscalQuarterEnding":"2025/09","expectedEps":-0.51,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2025-08-07","symbol":"WHWK","fiscalQuarterEnding":"2025/06","expectedEps":0.49,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.76}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WHWK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WHWK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.375,"hold":0.375,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1784001600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/WHWK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"WHWK","date":"2026-09-11","current":-3.690401,"percent":0.575676,"low":-12.311673,"twenty":-8.690593,"median":-6.306715,"eighty":-1.10918,"high":3.565526,"avg":-4.449917,"sd":4.596902,"marketCap":232026670},"quantilePoints":[{"date":"2025-03-21","current":-0.758488,"twenty":-0.777063,"median":-0.770098,"eighty":-0.763132,"marketCap":48308888},{"date":"2025-03-28","current":-0.735269,"twenty":-0.778611,"median":-0.758488,"eighty":-0.745331,"marketCap":46830044},{"date":"2025-04-04","current":-1.204672,"twenty":-1.122401,"median":-0.762358,"eighty":-0.739913,"marketCap":76726773},{"date":"2025-04-11","current":-1.189981,"twenty":-1.212018,"median":-0.793317,"eighty":-0.745331,"marketCap":75791081},{"date":"2025-04-17","current":-1.131217,"twenty":-1.219363,"median":-1.160599,"eighty":-0.754619,"marketCap":72048311},{"date":"2025-04-25","current":-1.10918,"twenty":-1.212018,"median":-1.134889,"eighty":-0.758488,"marketCap":70644773},{"date":"2025-05-02","current":-1.226709,"twenty":-1.212018,"median":-1.131217,"eighty":-0.766228,"marketCap":78130312},{"date":"2025-05-09","current":-1.204672,"twenty":-1.212018,"median":-1.145908,"eighty":-0.781707,"marketCap":76726773},{"date":"2025-05-16","current":2.863258,"twenty":-1.212018,"median":-1.131217,"eighty":-0.743009,"marketCap":79066004},{"date":"2025-05-23","current":3.185163,"twenty":-1.204672,"median":-1.098162,"eighty":2.795488,"marketCap":87955081},{"date":"2025-05-30","current":3.070788,"twenty":-1.204672,"median":-1.083471,"eighty":2.866646,"marketCap":84796727},{"date":"2025-06-06","current":2.866068,"twenty":-1.204672,"median":-0.793317,"eighty":2.88654,"marketCap":79143612},{"date":"2025-06-13","current":3.480226,"twenty":-1.198796,"median":-0.762358,"eighty":2.971113,"marketCap":96102957},{"date":"2025-06-20","current":3.497286,"twenty":-1.192919,"median":-0.748814,"eighty":3.05809,"marketCap":96574050},{"date":"2025-06-27","current":3.241387,"twenty":-1.185573,"median":-0.735269,"eighty":3.203855,"marketCap":89507656},{"date":"2025-07-03","current":3.394926,"twenty":-1.173821,"median":2.795488,"eighty":3.234563,"marketCap":93747493},{"date":"2025-07-11","current":3.360806,"twenty":-1.160599,"median":2.854787,"eighty":3.336922,"marketCap":92805307},{"date":"2025-07-18","current":3.156087,"twenty":-1.157661,"median":2.8802,"eighty":3.336922,"marketCap":87152192},{"date":"2025-07-25","current":3.309627,"twenty":-1.147377,"median":2.891658,"eighty":3.336922,"marketCap":91392028},{"date":"2025-08-01","current":2.985488,"twenty":-1.135624,"median":2.94797,"eighty":3.326686,"marketCap":82441262},{"date":"2025-08-08","current":-7.777691,"twenty":-1.135624,"median":2.968428,"eighty":3.326686,"marketCap":81027983},{"date":"2025-08-15","current":-7.328465,"twenty":-1.173821,"median":2.914085,"eighty":3.319862,"marketCap":76347946},{"date":"2025-08-22","current":-7.464177,"twenty":-1.204672,"median":2.883128,"eighty":3.309627,"marketCap":77761797},{"date":"2025-08-29","current":-8.007026,"twenty":-1.216425,"median":2.866068,"eighty":3.302803,"marketCap":83417200},{"date":"2025-09-05","current":-8.187976,"twenty":-1.245808,"median":2.846316,"eighty":3.286334,"marketCap":85302335},{"date":"2025-09-12","current":-9.092725,"twenty":-6.043814,"median":1.053329,"eighty":3.260812,"marketCap":94728007},{"date":"2025-09-19","current":-8.911775,"twenty":-7.464177,"median":-0.739139,"eighty":3.255035,"marketCap":92842873},{"date":"2025-09-26","current":-8.549876,"twenty":-7.726554,"median":-0.756554,"eighty":3.237975,"marketCap":89072604},{"date":"2025-10-03","current":-8.776063,"twenty":-7.907504,"median":-0.781707,"eighty":3.217503,"marketCap":91429022},{"date":"2025-10-10","current":-9.816524,"twenty":-8.133691,"median":-1.072452,"eighty":3.190207,"marketCap":102268545},{"date":"2025-10-17","current":-11.806971,"twenty":-8.187976,"median":-1.087143,"eighty":3.190207,"marketCap":123005024},{"date":"2025-10-24","current":-11.083172,"twenty":-8.377973,"median":-1.131217,"eighty":3.190207,"marketCap":115464486},{"date":"2025-10-31","current":-10.178423,"twenty":-8.631303,"median":-1.138562,"eighty":3.189198,"marketCap":106038814},{"date":"2025-11-07","current":-6.336891,"twenty":-8.67654,"median":-1.160599,"eighty":3.18276,"marketCap":98969560},{"date":"2025-11-14","current":-6.306715,"twenty":-8.64035,"median":-1.189981,"eighty":3.169735,"marketCap":98498276},{"date":"2025-11-21","current":-6.004958,"twenty":-8.631303,"median":-1.204672,"eighty":3.156087,"marketCap":93785440},{"date":"2025-11-28","current":-7.061107,"twenty":-8.595113,"median":-1.208345,"eighty":3.156087,"marketCap":110280367},{"date":"2025-12-05","current":-7.724972,"twenty":-8.595113,"median":-1.219363,"eighty":3.087847,"marketCap":120648606},{"date":"2025-12-12","current":-7.543918,"twenty":-8.549876,"median":-1.2414,"eighty":3.070788,"marketCap":117820905},{"date":"2025-12-19","current":-7.302512,"twenty":-8.414163,"median":-1.256091,"eighty":3.070788,"marketCap":114050636},{"date":"2025-12-26","current":-8.117255,"twenty":-8.269403,"median":-6.004958,"eighty":3.070788,"marketCap":126775293},{"date":"2026-01-02","current":-7.302512,"twenty":-8.233213,"median":-6.306715,"eighty":3.060552,"marketCap":114050636},{"date":"2026-01-09","current":-8.177607,"twenty":-8.206071,"median":-6.351978,"eighty":3.051266,"marketCap":127717861},{"date":"2026-01-16","current":-8.419012,"twenty":-8.259251,"median":-6.457593,"eighty":3.031614,"marketCap":131488129},{"date":"2026-01-23","current":-8.600066,"twenty":-8.417072,"median":-6.487769,"eighty":3.019608,"marketCap":134315831},{"date":"2026-01-30","current":-8.117255,"twenty":-8.404032,"median":-6.623559,"eighty":3.012784,"marketCap":126775293},{"date":"2026-02-06","current":-8.177607,"twenty":-8.49753,"median":-6.729174,"eighty":2.995724,"marketCap":127717861},{"date":"2026-02-13","current":-9.082877,"twenty":-8.545812,"median":-6.804614,"eighty":2.984034,"marketCap":141856369},{"date":"2026-02-20","current":-9.203579,"twenty":-8.599075,"median":-6.970579,"eighty":2.981854,"marketCap":143741504},{"date":"2026-02-27","current":-9.807093,"twenty":-8.64035,"median":-7.061107,"eighty":2.979169,"marketCap":153167176},{"date":"2026-03-06","current":-10.772714,"twenty":-8.689592,"median":-7.224988,"eighty":2.968428,"marketCap":168248252},{"date":"2026-03-13","current":-8.927379,"twenty":-8.771039,"median":-7.283227,"eighty":2.964336,"marketCap":183868304},{"date":"2026-03-20","current":-8.22663,"twenty":-8.780109,"median":-7.315488,"eighty":2.941193,"marketCap":169435664},{"date":"2026-03-27","current":-8.180799,"twenty":-8.776063,"median":-7.453391,"eighty":2.911306,"marketCap":168491733},{"date":"2026-04-02","current":-8.112053,"twenty":-8.776063,"median":-7.464177,"eighty":2.900188,"marketCap":167075836},{"date":"2026-04-10","current":-8.134968,"twenty":-8.750944,"median":-7.488959,"eighty":2.883128,"marketCap":167547802},{"date":"2026-04-17","current":-9.693215,"twenty":-8.776063,"median":-7.516252,"eighty":2.883128,"marketCap":199641465},{"date":"2026-04-24","current":-9.555723,"twenty":-8.866538,"median":-7.619357,"eighty":2.8802,"marketCap":196809671},{"date":"2026-05-01","current":-9.189077,"twenty":-8.927379,"median":-7.690364,"eighty":2.866068,"marketCap":189258221},{"date":"2026-05-08","current":-9.455575,"twenty":-9.00225,"median":-7.730287,"eighty":2.863258,"marketCap":194747017},{"date":"2026-05-15","current":-2.176776,"twenty":-8.959923,"median":-7.690364,"eighty":2.846316,"marketCap":252083702},{"date":"2026-05-22","current":-1.835321,"twenty":-8.937007,"median":-7.619357,"eighty":2.829373,"marketCap":212541161},{"date":"2026-05-29","current":-2.040194,"twenty":-8.937007,"median":-7.530085,"eighty":2.802265,"marketCap":236266686},{"date":"2026-06-05","current":-1.878925,"twenty":-8.929305,"median":-7.513742,"eighty":0.008033,"marketCap":217590837},{"date":"2026-06-12","current":-1.733736,"twenty":-8.914896,"median":-7.464177,"eighty":-0.725981,"marketCap":200776999},{"date":"2026-06-18","current":-1.80206,"twenty":-8.911775,"median":-7.408127,"eighty":-0.737591,"marketCap":208689393},{"date":"2026-06-26","current":-1.908791,"twenty":-8.887698,"median":-7.302512,"eighty":-0.741461,"marketCap":221049482},{"date":"2026-07-02","current":-1.997032,"twenty":-8.869603,"median":-7.283227,"eighty":-0.747653,"marketCap":231268314},{"date":"2026-07-10","current":-1.792685,"twenty":-8.848443,"median":-7.239629,"eighty":-0.756167,"marketCap":207603649},{"date":"2026-07-17","current":-1.806618,"twenty":-8.8213,"median":-7.121458,"eighty":-0.761584,"marketCap":209217149},{"date":"2026-07-24","current":-1.778752,"twenty":-8.805228,"median":-7.030931,"eighty":-0.77242,"marketCap":205990150},{"date":"2026-07-31","current":-1.78804,"twenty":-8.780109,"median":-6.880052,"eighty":-0.784029,"marketCap":207065816},{"date":"2026-08-07","current":-3.16646,"twenty":-8.776063,"median":-6.75935,"eighty":-0.847675,"marketCap":252781646},{"date":"2026-08-14","current":-3.342087,"twenty":-8.771039,"median":-6.698999,"eighty":-1.068044,"marketCap":266802166},{"date":"2026-08-21","current":-3.449205,"twenty":-8.750944,"median":-6.578296,"eighty":-1.081267,"marketCap":275353518},{"date":"2026-08-28","current":-3.47777,"twenty":-8.746909,"median":-6.457593,"eighty":-1.087143,"marketCap":277633878},{"date":"2026-09-04","current":-3.306381,"twenty":-8.722733,"median":-6.367066,"eighty":-1.09155,"marketCap":263951716},{"date":"2026-09-11","current":-2.906473,"twenty":-8.690593,"median":-6.306715,"eighty":-1.10918,"marketCap":232026670}],"updateTime":1789216873194},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"WHWK\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633412903","title":"Whitehawk Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633412903","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633412903?lang=en_us&edition=fundamental","pubTime":"2026-05-07 23:28","pubTimestamp":1778167717,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryWhitehawk Therapeutics Inc WHWK.OQ reported a quarterly adjusted loss of 32 cents per share for the quarter ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL8N41K2A3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144774","title":"Whitehawk Therapeutics posts corporate deck outlining three-asset antibody-drug conjugate pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144774","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633144774?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:17","pubTimestamp":1778156233,"startTime":"0","endTime":"0","summary":"Whitehawk outlined a three-asset antibody-drug conjugate portfolio, including 2 clinical-stage programs and an IND expected mid-2026.Cash as of March 31, 2026 was USD 123 million, with runway expected into 2028 under current plans.Platform positioned around a DAR6 TOP1 inhibitor payload and cleavable linker, with preclinical benchmarks cited at 3-10x greater potency, 5-25x higher stability, and 2-3x higher safety margin versus an average TOP1 inhibitor ADC platform.Lead programs include HWK-007 targeting PTK7 and HWK-016 targeting MUC16, with first data readouts expected in 1H 2027.Third program HWK-206 targets SEZ6, with Phase 1 planned in small cell lung cancer and neuroendocrine neoplasms.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLdv0b9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","WHWK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144325","title":"Whitehawk Q1 net loss turns to USD 22.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144325","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633144325?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:04","pubTimestamp":1778155486,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics posted a net loss of USD 22.2 million, swinging from net income of USD 73 million a year earlier.Research and development expenses climbed to USD 17.2 million from USD 8.8 million, including USD 5.3 million of development milestone expenses under a license agreement with WuXi Biologics.Cash, cash equivalents, short-term investments fell to USD 123 million at March 31 from USD 145.7 million at Dec. 31; cash runway seen funding operations into 2028.Phase 1 dose-escalation studies for HWK-007 and HWK-016 continued enrolling; IND submission for HWK-206 remains on track for mid-2026 with Phase 1 recruitment planned to start in Q3 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL6tttYH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764599.SGD","LU0307460666.USD","LU0359201612.USD","LU0516422366.SGD","BK1589","LU1794554557.SGD","BK4139","LU0823426480.USD","LU0327786744.USD","LU0588546209.SGD","LU0359202008.SGD","LU0140636845.USD","LU0051755006.USD","SG9999002562.SGD","LU0708995583.HKD","LU0039217434.USD","LU0052750758.USD","LU1242518857.USD","WHWK","LU0326950275.SGD","LU1880383366.USD","LU0516422440.USD","LU0417516902.SGD","LU0456827905.SGD","LU1688375341.USD","BK1141","BK1610","LU0516423091.SGD","LU1242518931.SGD","LU1720050803.USD","LU0456846285.SGD","LU0572944931.SGD","LU0979878070.USD","LU0819121731.USD","LU0348735423.USD","02269","LU0181495838.USD","LU3063872942.SGD","LU0856984785.SGD","BK1576","LU0516422952.EUR","LU0823426308.USD","LU0417516738.SGD","BK1521","LU0043850808.USD","LU0516423174.USD","LU2039709279.SGD","IE00B0JY6N72.USD","LU0348825331.USD","SG9999002463.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633412211","title":"WhiteHawk Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2633412211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633412211?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:00","pubTimestamp":1778155206,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA8S4RTT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","WHWK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633396241","title":"Whitehawk Therapeutics Inc  expected to post a loss of 9 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633396241","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633396241?lang=en_us&edition=fundamental","pubTime":"2026-05-05 07:03","pubTimestamp":1777935787,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics Inc  expected to post a loss of9cents a share - Earnings Preview Whitehawk Therapeutics Inc WHWK.OQ WHWK.O is expected to  show a fall in quarterly revenue when it reports  resu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL8N41H2O6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631535022","title":"Whitehawk Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2631535022","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631535022?lang=en_us&edition=fundamental","pubTime":"2026-04-29 04:29","pubTimestamp":1777408188,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics scheduled 2026 annual shareholder meeting for June 11, 2026, to be held online.Shareholders will vote on election of three Class III directors to serve until 2029.Meeting agenda includes advisory vote on compensation for named executive officers for fiscal 2025.Proposal also seeks ratification of BDO USA as independent registered accounting firm for fiscal 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 28, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL5ZyZYL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","WHWK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629305544","title":"Whitehawk Therapeutics' Antibody Drug Conjugates Indicate Potential Efficacy Against Cancer, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2629305544","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629305544?lang=en_us&edition=fundamental","pubTime":"2026-04-21 23:56","pubTimestamp":1776787016,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics (WHWK) presented \"solid\" preclinical datasets for its early stage antibody drug conjugates, or ADCs, indicating \"substantial clinical evidence\" of their potential efficacy again","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WHWK","OPY","BK4139","BK4007","BK4127","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629039602","title":"Oppenheimer Sticks to Their Buy Rating for Whitehawk Therapeutics (WHWK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629039602","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629039602?lang=en_us&edition=fundamental","pubTime":"2026-04-21 20:17","pubTimestamp":1776773865,"startTime":"0","endTime":"0","summary":"In a report released today, Jeff Jones from Oppenheimer reiterated a Buy rating on Whitehawk Therapeutics, with a price target of $6.00. According ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-their-buy-rating-for-whitehawk-therapeutics-whwk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-their-buy-rating-for-whitehawk-therapeutics-whwk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","WHWK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629603809","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Whitehawk Therapeutics (WHWK), COMPASS Pathways (CMPS) and Monopar Therapeutics Inc (MNPR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629603809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629603809?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:00","pubTimestamp":1776769222,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Whitehawk Therapeutics (WHWK), COMPASS Pathways (CMPS) and Monopa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-whitehawk-therapeutics-whwk-compass-pathways-cmps-and-monopar-therapeutics-inc-mnpr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-whitehawk-therapeutics-whwk-compass-pathways-cmps-and-monopar-therapeutics-inc-mnpr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","CMPS","HCSG","LU0029874061.USD","WHWK","BK4581","LABU","XBI","XLV","MNPR","LU0128526141.USD","BK4137","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628156937","title":"Whitehawk Therapeutics publishes HWK-016 preclinical presentation on MUC16-targeting ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2628156937","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628156937?lang=en_us&edition=fundamental","pubTime":"2026-04-20 11:45","pubTimestamp":1776656716,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics published preclinical data for HWK-016, a MUC16-targeting antibody-drug conjugate designed to bind non-shed MUC16 extracellular domain rather than circulating CA125.In cell assays, exogenous CA125 at 10,623 U/mL shifted HWK-016 antibody binding EC50 3-fold to 0.67 nM from 0.22 nM.In an ovarian cancer OVCAR-3 xenograft model, HWK-016 produced 108% tumor growth inhibition at 6 mg/kg with 4 complete responses out of 7 animals.Repeat-dose toxicology in cynomolgus monkeys showed highest non-severely toxic dose of 60 mg/kg with no mortalities reported.Whitehawk said HWK-016 is being evaluated in a Phase 1 study in advanced ovarian or endometrial cancers .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therape","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL73cXRD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628924267","title":"Whitehawk announces presentation of new preclinical data across ADC portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2628924267","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628924267?lang=en_us&edition=fundamental","pubTime":"2026-04-20 08:45","pubTimestamp":1776645907,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics (WHWK) announced the presentation of new preclinical data across its ADC portfolio at the American Association for Cancer Re...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/whitehawk-announces-presentation-of-new-preclinical-data-across-adc-portfolio-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/whitehawk-announces-presentation-of-new-preclinical-data-across-adc-portfolio-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4080","BK4231","BK4139","ADC","WHWK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628042796","title":"Whitehawk says Phase 1 trial for HWK-016 ADC in ovarian, endometrial cancers ongoing","url":"https://stock-news.laohu8.com/highlight/detail?id=2628042796","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628042796?lang=en_us&edition=fundamental","pubTime":"2026-04-20 06:00","pubTimestamp":1776636034,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics announced new preclinical data on its next-generation antibody-drug conjugate portfolio at AACR 2026, with results presented at the meeting.Data showed tumor shrinkage across multiple models with a safety profile described as favorable, supporting a differentiated risk-benefit profile for its platform.Ongoing Phase 1 trials for HWK-007 and HWK-016 remained active, with the update framed as supportive of continued clinical development.Plans call for an IND filing for HWK-206 in mid-2026, positioning a Phase 1 start in Q3 2026 as the next value-driving catalyst.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260419:nNDL4g5Qrm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","WHWK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628246762","title":"Whitehawk Therapeutics CEO joins Jones Trading Post-AACR virtual fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2628246762","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628246762?lang=en_us&edition=fundamental","pubTime":"2026-04-17 04:06","pubTimestamp":1776369990,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics CEO Dave Lennon scheduled to join Jones Trading Post-AACR virtual fireside chat on April 23, 2026 at 3 p.m. ET.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL5wyT0t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","WHWK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627624103","title":"Whitehawk Therapeutics publishes ovarian cancer MUC16 expression study presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2627624103","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627624103?lang=en_us&edition=fundamental","pubTime":"2026-04-13 00:22","pubTimestamp":1776010934,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics published a medical research presentation on MUC16 expression patterns in ovarian cancer to support development of MUC16-targeted antibody-drug conjugates.Analysis cited MUC16 overexpression in about 80% of epithelial ovarian cancers, with limited expression in normal tissue.Data showed MUC16 protein abundance in serous ovarian carcinoma tumor samples was 1.35-fold higher than normal adjacent tissue.RNA-sequencing results across 5,227 ovarian cancer tumors showed robust expression across histologic subtypes, with lowest median expression in mucinous adenocarcinoma.Whitehawk’s investigational MUC16-targeted ADC, HWK-016, is in a phase 1 trial for advanced gynecological cancers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or leg","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260412:nNDL6cvW9M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626126169","title":"Trade Alert: President Of Whitehawk Therapeutics David Lennon Has Sold Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2626126169","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626126169?lang=en_us&edition=fundamental","pubTime":"2026-04-11 20:30","pubTimestamp":1775910649,"startTime":"0","endTime":"0","summary":"Some Whitehawk Therapeutics, Inc. ( NASDAQ:WHWK ) shareholders may be a little concerned to see that the President...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-whwk/whitehawk-therapeutics/news/trade-alert-president-of-whitehawk-therapeutics-david-lennon","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-whwk/whitehawk-therapeutics/news/trade-alert-president-of-whitehawk-therapeutics-david-lennon","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LENZ","BK4139","BK4007","WHWK","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626176194","title":"Whitehawk Therapeutics presents analysis of MUC16 at SGO","url":"https://stock-news.laohu8.com/highlight/detail?id=2626176194","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626176194?lang=en_us&edition=fundamental","pubTime":"2026-04-10 19:13","pubTimestamp":1775819622,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics (WHWK) presented three posters from a real-world analysis supporting the therapeutic potential of targeting mucin 16 with a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/whitehawk-therapeutics-presents-analysis-of-muc16-at-sgo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/whitehawk-therapeutics-presents-analysis-of-muc16-at-sgo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WHWK","BK4539","BK4007","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626910061","title":"Whitehawk says Phase 1 trial tests MUC16-targeted ADC HWK-016 in gynecologic cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2626910061","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626910061?lang=en_us&edition=fundamental","pubTime":"2026-04-10 19:01","pubTimestamp":1775818894,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics presented real-world analysis at SGO 2026 supporting MUC16 as a highly expressed, clinically relevant target in ovarian cancer and key endometrial cancer subtypes.Findings reinforced business case for HWK-016, Whitehawk’s MUC16-directed antibody-drug conjugate in Phase 1 for advanced ovarian and endometrial cancers.Analysis indicated MUC16 expression remains consistent across disease settings, supporting potential use in earlier-line treatment and in heavily pretreated patients.Whitehawk expects initial clinical data from HWK-016 Phase 1 trial in first half of 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDLbp20v4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","WHWK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625960105","title":"JonesTrading Sticks to Their Buy Rating for Whitehawk Therapeutics (WHWK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625960105","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625960105?lang=en_us&edition=fundamental","pubTime":"2026-04-07 04:37","pubTimestamp":1775507833,"startTime":"0","endTime":"0","summary":"In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on Whitehawk Therapeutics, with a price target of $7.00. According...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jonestrading-sticks-to-their-buy-rating-for-whitehawk-therapeutics-whwk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jonestrading-sticks-to-their-buy-rating-for-whitehawk-therapeutics-whwk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WHWK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620403823","title":"Whitehawk Therapeutics to present three preclinical ADC abstracts at AACR Annual Meeting 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620403823","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620403823?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:30","pubTimestamp":1773779438,"startTime":"0","endTime":"0","summary":"Whitehawk will present three preclinical abstracts at the AACR Annual Meeting 2026 in San Diego on April 17-22, 2026. David Dornan is scheduled to give an oral minisymposium presentation on April 19, 2026, from 3:00-5:00 pm. Kathleen Keegan is scheduled to present two posters on April 21, 2026, from 9:00 am-12:00 pm.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL56s5lT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620420283","title":"Whitehawk Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2620420283","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620420283?lang=en_us&edition=fundamental","pubTime":"2026-03-17 21:31","pubTimestamp":1773754273,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryWhitehawk Therapeutics Inc WHWK.OQ reported a quarterly adjusted loss of 34 cents per share for the quart","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nL8N4051D8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":60,"code":"91000000","status":"200"}]}}